Leerink Partners Raises Price Target on Stryker (SYK) to $125 Following 1Q Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Becton Dickinson (BDX) Announces Sale of Vertebral Augmentation Solutions Business to Stryker
April 21, 2016 7:35 AM EDTBD (Becton, Dickinson and Company) (NYSE: BDX), a leading medical technology company, announced today that it has sold its vertebral augmentation solutions business, which includes all AVAmax®, AVAflex®, AVAtex® and AVAprep® branded products to Stryker.
This sale will not have a material impact to... More
Stryker (SYK) Tops Q1 EPS by 4c, Boosts FY Gudiance
April 20, 2016 4:10 PM EDTStryker (NYSE: SYK) reported Q1 EPS of $1.24, $0.04 better than the analyst estimate of $1.20. Revenue for the quarter came in at $2.5 billion versus the consensus estimate of $2.47 billion.
GUIDANCE:
Stryker sees Q2 2016 EPS of $1.33-$1.38, versus the consensus of... More
